US FDA creates new webpage on post-market device studies
This article was originally published in RAJ Devices
The US Food and Drug Administration has launched a new webpage to inform the public about post-approval studies conducted with medical devices1. The initiative forms part of the agency's efforts to increase transparency about its processes2.
You may also be interested in...
The European Medicines Agency will hold a webinar to explain and demonstrate specific functionalities of the new clinical trials system relevant to clinical trial sponsors.
New guidance explains how UK-based sites and organizations can facilitate routine on-site good practice inspections that are due to restart next month.
A class review of Canadian product monographs for various insulin products has revealed inconsistencies.